Arrivent BioPharma, Inc. (AVBP)
20.86
-1.04
(-4.75%)
USD |
NASDAQ |
Jan 16, 16:00
20.84
-0.02
(-0.10%)
After-Hours: 20:00
Arrivent BioPharma EPS Diluted (Quarterly): -0.8345 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 1.432 |
| AIM ImmunoTech, Inc. | -1.567 |
| Annexon, Inc. | -0.3683 |
| Spruce Biosciences, Inc. | -14.58 |
| CEL-SCI Corp. | -0.7611 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -34.98M |
| Total Expenses (Quarterly) | 34.98M |
| Enterprise Value | 546.06M |
| Earnings Yield | -20.30% |
| Normalized Earnings Yield | -20.30 |